Literature DB >> 3901260

Concept of hypercoagulability: a review of its development, clinical application, and recent progress.

C S Kitchens.   

Abstract

There exist multiple clinical conditions, situations, and diseases in which persons appear to be at increased risk for thromboembolic phenomena, such as venous thrombosis and pulmonary embolus. Within this group of conditions, situations, or diseases, some are more clearly linked to thromboembolism that others. Similarly, for some, there exist clear biochemical reasons to support a proposed causal mechanism. A categorization of these risk factors has been constructed, taking into account both the apparent association of the risk factor with thromboembolism and the credibility of the proposed mechanism. Forty-eight factors have been so stratified. It is predicted that both more factors will be identified and especially that mechanisms proposed will strengthen as this area of medicine is further investigated.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3901260     DOI: 10.1055/s-2007-1004383

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  9 in total

Review 1.  Clearance of thrombin in vivo: significance of alternative pathways.

Authors:  T H Carlson
Journal:  Mol Cell Biochem       Date:  1986-08       Impact factor: 3.396

Review 2.  Risk-benefit assessment of anticoagulant therapy.

Authors:  R Harrington; J Ansell
Journal:  Drug Saf       Date:  1991 Jan-Feb       Impact factor: 5.606

3.  Combined presence of coagulation factor XIII V34L and plasminogen activator inhibitor 1 4G/5G gene polymorphisms significantly contribute to recurrent pregnancy loss in Serbian population.

Authors:  Ivana Joksic; Zeljko Mikovic; Dejan Filimonovic; Jelena Munjas; Orlic Natasa Karadzov; Amira Egic; Gordana Joksic
Journal:  J Med Biochem       Date:  2020-01-23       Impact factor: 3.402

4.  Thromboembolic phenomena in neurosurgical patients operated upon for primary and metastatic brain tumors.

Authors:  S Constantini; R Kornowski; S Pomeranz; Z H Rappaport
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

5.  Management and prevention of thromboembolic events in patients with cancer-related hypercoagulable states: a risky business.

Authors:  F P Sarasin; M H Eckman
Journal:  J Gen Intern Med       Date:  1993-09       Impact factor: 5.128

6.  Prothrombotic abnormalities in inflammatory bowel disease.

Authors:  M G Conlan; W D Haire; D A Burnett
Journal:  Dig Dis Sci       Date:  1989-07       Impact factor: 3.199

Review 7.  Thromboembolic complications associated with brain tumors.

Authors:  R E Sawaya; B L Ligon
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 8.  Hemostatic changes in patients with brain tumors.

Authors:  L Thoron; E Arbit
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

9.  Hemostatic disorders in feline immunodeficiency virus-seropositive cats.

Authors:  S W Hart; I Nolte
Journal:  J Vet Intern Med       Date:  1994 Sep-Oct       Impact factor: 3.333

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.